Adam Elhofy

Adam Elhofy

Company: COUR Pharmaceuticals

Job title: Director of Immunology


Antigen-Specific Tolerance to Multiple Epitopes in T1D 3:30 pm

Discussing how antigen-specific tolerance to multiple proteins stops progression to overt diabetes in the NOD model Tolerance induction by CNP-T1D included upregulation Tregs and TR1 cell populations, which resulted in inhibition of activation of diabetogenic epitopes not encapsulated within CNP The CNP-T1D induced tolerance was durable to the end of the study and also prevented…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.